Vanda Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VNDA and other ETFs, options, and stocks.

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.

CEO

Mihael Hristos Polymeropoulos

CEOMihael Hristos Polymeropoulos

Employees

368

Employees368

Headquarters

Washington, District of Columbia

HeadquartersWashington, District of Columbia

Founded

2002

Founded2002

Employees

368

Employees368

VNDA Key Statistics

Market cap

276.40M

Market cap276.40M

Price-Earnings ratio

-6.18

Price-Earnings ratio-6.18

Dividend yield

—

Dividend yield—

Average volume

438.22K

Average volume438.22K

High today

—

High today—

Low today

—

Low today—

Open price

$4.69

Open price$4.69

Volume

0.00

Volume0.00

52 Week high

$6.37

52 Week high$6.37

52 Week low

$3.81

52 Week low$3.81

People also own

Based on the portfolios of people who own VNDA. This list is generated using Robinhood data, and it’s not a recommendation.